Journal of Multiple Sclerosis and Neuroimmunology

Most read articles

Page Path

HOME
BROWSE ARTICLES
Most read articles

From articles published in J Mult Scler Neuroimmunol during the past two years (2024~ ).

Review Article

Autoimmune Nodopathy: When to Suspect and How to Treat? (3,349 times): Young Gi Min, Ha Young Shin, Jung-Joon Sung; J Mult Scler Neuroimmunol. 2024;15(1):23-30. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.23; Full text PubReader ePub PDF

Original Article

National Consensus Guidance for Management of Refractory Myasthenia Gravis (3,015 times): Hyung-Soo Lee, Hye Yoon Chung, Seung Woo Kim, Eunhee Sohn, Tai-Seung Nam, Kyong Jin Shin, Sa-Yoon Kang, Hyunjin Kim, Jin-Sung Park, Byeol-A Yoon, Hung Youl Seok, Jeong Bin Bong, Yeon-Kyung Jung, Yoon-Ho Hong, Ha Young Shin; J Mult Scler Neuroimmunol. 2024;15(2):59-71. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.59-71
Cited By 1; Full text PubReader ePub PDF

Review Article

Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder (2,107 times): Jae-Won Hyun; J Mult Scler Neuroimmunol. 2024;15(1):17-22. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.17; Full text PubReader ePub PDF

Review Article

Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis (1,955 times): Jiwon Yang; J Mult Scler Neuroimmunol. 2024;15(1):1-6. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.1; Full text PubReader ePub PDF Supplementary Material

Case Report

Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis (1,515 times): Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2024;15(1):31-34. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.31; Full text PubReader ePub PDF

Review Article

Imaging Biomarkers for Differential Diagnosis of Central Nervous System Inflammatory Diseases (1,472 times): Soonwook Kwon; J Mult Scler Neuroimmunol. 2024;15(1):7-16. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.7; Full text PubReader ePub PDF

Case Report

Emotional Incontinence in a Patient with Neuromyelitis Optica Spectrum Disorder (1,428 times): Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(1):35-39. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.35; Full text PubReader ePub PDF

Original Article

Temporal Association between Thymoma Recurrence and Exacerbation of Myasthenia Gravis (1,390 times): Byeong Cheol Oh, Ha Young Shin, Young Ho Yang, Seung Woo Kim; J Mult Scler Neuroimmunol. 2024;15(2):72-80. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.72-80; Full text PubReader ePub PDF Supplementary Material

Review Article

Collaboration between Medical Association and Patient Organizations to Overcome Rare Neurological Disorders (1,369 times): Ki Hoon Kim, Young Nam Kwon, Jun-Soon Kim, Sooyoung Kim, Seung Woo Kim, Kee Hong Park, Jin-Sung Park, Jeong Bin Bong, Jin Myoung Seok, Hung Youl Seok, Hye Lim Lee, Eunbin Cho, Byeoung-Jun Jeon, Seong-il Oh, Public Relations Committee of Korean Society for Neuroimmunology; J Mult Scler Neuroimmunol. 2025;16(1):8-18. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.8-18; Full text PubReader ePub PDF

Neuroimage

An Immunoglobulin G4-Related Hypertrophic Pachymeningitis Involving Cerebral Parenchyma (1,283 times): Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2024;15(1):40-41. Published online June 30, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.1.40; Full text PubReader ePub PDF

Neuroimage

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis (1,157 times): Jun-Soon Kim; J Mult Scler Neuroimmunol. 2024;15(2):85-86. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.85-86
Cited By 1; Full text PubReader ePub PDF

Review Article

Eculizumab Therapy in Neuromyelitis Optica Spectrum Disorder (1,154 times): Jee Eun Kim, Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(2):43-48. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.43-48; Full text PubReader ePub PDF

Review Article

The Clinical Utility of the Ocrelizumab for the Patients with Multiple Sclerorsis (1,145 times): Suk-Won Ahn; J Mult Scler Neuroimmunol. 2024;15(2):49-54. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.49-54; Full text PubReader ePub PDF

Case Report

A Case Report of MOG Antibody-Associated Disease (MOGAD) with Isolated Brainstem and Spinal Cord Involvement (1,059 times): Ye Lin Kim, Juhee Chae, Sun-Young Oh; J Mult Scler Neuroimmunol. 2024;15(2):81-84. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.81-84; Full text PubReader ePub PDF

Case Report

Clinical Manifestation and Prognosis of Overlapping Acute Motor Axonal Neuropathy and Acute Transverse Myelitis with Anti-GM1 and Anti-GD1a Antibodies: A Case Study (1,014 times): A Young Kim, Hong Keun Yoo, Jong Hyun Jeon, Hyuk Sung Kwon; J Mult Scler Neuroimmunol. 2025;16(1):26-32. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.26-32; Full text PubReader ePub PDF

Review Article

Diagnosis and Management of Neurological Immune Related Adverse Events (954 times): Jae-Won Hyun; J Mult Scler Neuroimmunol. 2025;16(1):1-7. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.1-7; Full text PubReader ePub PDF

Original Article

Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France (836 times): Grégoire Mercier, David Pau, Guillaume Bourel, Manon Belhassen, Floriane Deygas, Clarisse Marchal, Sophie Larrieu, Alexandre Civet, Xavier Moisset; J Mult Scler Neuroimmunol. 2025;16(1):19-25. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.19-25; Full text PubReader ePub PDF Supplementary Material

Review Article

Summary of Cladribine (from Development to Clinical and Practical Treatment) (827 times): Kyong Jin Shin; J Mult Scler Neuroimmunol. 2024;15(2):55-58. Published online December 31, 2024; DOI: https://doi.org/10.59578/jmsni.2024.15.2.55-58; Full text PubReader ePub PDF

Letter to the Editor

The Importance of Cautious Interpretation and Differential Diagnosis in Low-Titer MOG Antibody Positivity (825 times): Jae-Won Hyun, Ho Jin Kim; J Mult Scler Neuroimmunol. 2025;16(1):33-34. Published online June 30, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.1.33-34; Full text PubReader ePub PDF

Review Article

Cognitive Dysfunction and Assessment in Multiple Sclerosis (136 times): Eun Oh, Seong-il Oh; J Mult Scler Neuroimmunol. 2025;16(2):35-44. Published online December 31, 2025; DOI: https://doi.org/10.59578/jmsni.2025.16.2.35-44; Full text PubReader ePub PDF

Volume 16, No. 2

Journal of Multiple
Sclerosis and
Neuroimmunology

Print ISSN: 2733-8290
Online ISSN: 2951-2972

MOST VIEWED MOST CITED

3,349	Autoimmune Nodopathy: When to Suspect and How to Treat?
3,015	National Consensus Guidance for Management of Refractory Myasthenia Gravis
2,107	Monoclonal Antibody Treatment for Relapse Prevention in Neuromyelitis Optica Spectrum Disorder
1,955	Clinicoradiological Factors for Predicting and Monitoring the Progression of Multiple Sclerosis
1,515	Severe Neutropenia Following Rituximab Treatment in Patients with Multiple Sclerosis

Cited By 1	National Consensus Guidance for Management of Refractory Myasthenia Gravis
Cited By 1	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Presenting as a Diffuse Pachymeningitis

Editorial Office: Department of Neurology, Chung-Ang University Hospital, Chung-Ang University College of Medicine 102, Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-3153 E-mail: jmsni@koreams.org

Copyright © 2026 by Korean Society of Neuroimmunology.